−3.00HKD
−933.13 MHKD
139.15 MHKD
153.22 M
About EVEREST MEDICINES LTD
Sector
CEO
Yong Qing Luo
Headquarters
Shanghai
Website
Employees (FY)
432
Founded
2017
ISIN
KYG3224E1061
FIGI
BBG00XJ8RXX1
Everest Medicines Ltd. is a biopharmaceutical company, which engages in the developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asian markets. Its therapeutic areas of interest include oncology, autoimmune disorders, cardio-renal diseases, and infectious diseases. The company was founded in July 2017 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1952 is 23.60 HKD — it has increased by 1.07% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange EVEREST MEDICINES LTD stocks are traded under the ticker 1952.
EVEREST MEDICINES LTD is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
1952 stock is 4.14% volatile and has beta coefficient of 1.93. Check out the list of the most volatile stocks — is EVEREST MEDICINES LTD there?
One year price forecast for EVEREST MEDICINES LTD has a max estimate of 30.00 HKD and a min estimate of 24.05 HKD.
1952 earnings for the last quarter are −1.51 HKD per share, whereas the estimation was −2.28 HKD resulting in a 33.65% surprise. The estimated earnings for the next quarter are −1.91 HKD per share. See more details about EVEREST MEDICINES LTD earnings.
EVEREST MEDICINES LTD revenue for the last quarter amounts to 9.61 M HKD despite the estimated figure of 15.60 M HKD. In the next quarter revenue is expected to reach 127.29 M HKD.
Yes, you can track EVEREST MEDICINES LTD financials in yearly and quarterly reports right on TradingView.
1952 stock has risen by 0.43% compared to the previous week, the month change is a 5.60% fall, over the last year EVEREST MEDICINES LTD has showed a 63.21% increase.
1952 net income for the last quarter is −454.66 M HKD, while the quarter before that showed −479.09 M HKD of net income which accounts for 5.10% change. Track more EVEREST MEDICINES LTD financial stats to get the full picture.
Today EVEREST MEDICINES LTD has the market capitalization of 6.89 B, it has increased by 7.10% over the last week.
No, 1952 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1952 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EVEREST MEDICINES LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 432.00 employees. See our rating of the largest employees — is EVEREST MEDICINES LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EVEREST MEDICINES LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EVEREST MEDICINES LTD stock shows the buy signal. See more of EVEREST MEDICINES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on EVEREST MEDICINES LTD future price: according to them, 1952 price has a max estimate of 30.00 HKD and a min estimate of 24.03 HKD. Read a more detailed EVEREST MEDICINES LTD forecast: see what analysts think of EVEREST MEDICINES LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EVEREST MEDICINES LTD EBITDA is −850.21 M HKD, and current EBITDA margin is −610.12%. See more stats in EVEREST MEDICINES LTD financial statements.